pegylated interferon alpha-2b

DRUG6 trials

Conditions

Carcinoma, Squamous CellHepatitis BHepatitis B, ChronicHepatitis C, ChronicJuvenile Pilocytic AstrocytomasMelanomaOptic Pathway GliomasSquamous Cell Carcinoma of Skin

Phase 1

Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion

TerminatedNCT00791271

M.D. Anderson Cancer CenterMelanoma

Start: 2008-09-02End: 2015-05-31Updated: 2018-11-09

Phase 2

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

CompletedNCT02218164

H. Lee Moffitt Cancer Center and Research InstituteCarcinoma, Squamous Cell, Squamous Cell Carcinoma of Skin

Start: 2014-08-12End: 2018-06-25Updated: 2022-10-07

Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

CompletedNCT02343224

Emory UniversityJuvenile Pilocytic Astrocytomas, Optic Pathway Gliomas

Start: 2014-11-30End: 2020-11-11Updated: 2022-01-24

Phase 3

PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327)

CompletedNCT00536263

Merck Sharp & Dohme LLCHepatitis B, Chronic

Start: 2007-09-30End: 2009-11-30Updated: 2017-04-07

Phase 4

Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients

TerminatedNCT00803309

HepNet Study House, German LiverfoundationHepatitis C, Chronic

Start: 2008-11-30End: 2013-08-31Updated: 2017-08-28

Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients

TerminatedNCT00803309

HepNet Study House, German LiverfoundationHepatitis C, Chronic

Start: 2008-11-30End: 2013-08-31Updated: 2017-08-28

A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)

WithdrawnNCT01727271

Merck Sharp & Dohme LLCHepatitis B

Start: 2013-08-31End: 2017-08-31Updated: 2013-09-19

Related Papers

A phase II study of capecitabine (Cape) or 5-fluorouracil (5-FU) with pegylated interferon alpha-2b (Peg-IFNA-2b) in unresectable/metastatic cutaneous squamous cell carcinoma (CSCC).

Journal of Clinical Oncology2019-05-20

Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial

PLoS ONE2015-06-098 citations